nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP3A4—type 2 diabetes mellitus	0.212	1	CbGaD
Bexarotene—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0384	0.0821	CbGbCtD
Bexarotene—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0351	0.0751	CbGbCtD
Bexarotene—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0327	0.0698	CbGbCtD
Bexarotene—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0278	0.0594	CbGbCtD
Bexarotene—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0278	0.0594	CbGbCtD
Bexarotene—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0256	0.0548	CbGbCtD
Bexarotene—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0251	0.0536	CbGbCtD
Bexarotene—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0248	0.0529	CbGbCtD
Bexarotene—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0226	0.0484	CbGbCtD
Bexarotene—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0223	0.0478	CbGbCtD
Bexarotene—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0211	0.045	CbGbCtD
Bexarotene—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0204	0.0437	CbGbCtD
Bexarotene—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0202	0.0431	CbGbCtD
Bexarotene—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0179	0.0382	CbGbCtD
Bexarotene—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0162	0.0345	CbGbCtD
Bexarotene—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0142	0.0304	CbGbCtD
Bexarotene—CYP2C9—Losartan—type 2 diabetes mellitus	0.013	0.0278	CbGbCtD
Bexarotene—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0122	0.0262	CbGbCtD
Bexarotene—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0117	0.0251	CbGbCtD
Bexarotene—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0117	0.0251	CbGbCtD
Bexarotene—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0111	0.0237	CbGbCtD
Bexarotene—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00827	0.0177	CbGbCtD
Bexarotene—CYP3A4—Losartan—type 2 diabetes mellitus	0.00756	0.0162	CbGbCtD
Bexarotene—Agitation—Losartan—type 2 diabetes mellitus	8.28e-05	0.000401	CcSEcCtD
Bexarotene—Oedema—Metformin—type 2 diabetes mellitus	8.28e-05	0.000401	CcSEcCtD
Bexarotene—Tinnitus—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000401	CcSEcCtD
Bexarotene—Hypertension—Irbesartan—type 2 diabetes mellitus	8.26e-05	0.0004	CcSEcCtD
Bexarotene—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.25e-05	0.000399	CcSEcCtD
Bexarotene—Infection—Metformin—type 2 diabetes mellitus	8.22e-05	0.000398	CcSEcCtD
Bexarotene—Insomnia—Valsartan—type 2 diabetes mellitus	8.22e-05	0.000398	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.18e-05	0.000396	CcSEcCtD
Bexarotene—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.16e-05	0.000395	CcSEcCtD
Bexarotene—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.15e-05	0.000395	CcSEcCtD
Bexarotene—Chest pain—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.000395	CcSEcCtD
Bexarotene—Arthralgia—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.000395	CcSEcCtD
Bexarotene—Myalgia—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.000395	CcSEcCtD
Bexarotene—Shock—Metformin—type 2 diabetes mellitus	8.14e-05	0.000394	CcSEcCtD
Bexarotene—Insomnia—Orlistat—type 2 diabetes mellitus	8.12e-05	0.000394	CcSEcCtD
Bexarotene—Malaise—Losartan—type 2 diabetes mellitus	8.12e-05	0.000393	CcSEcCtD
Bexarotene—Anxiety—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000393	CcSEcCtD
Bexarotene—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.12e-05	0.000393	CcSEcCtD
Bexarotene—Nervous system disorder—Metformin—type 2 diabetes mellitus	8.12e-05	0.000393	CcSEcCtD
Bexarotene—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.11e-05	0.000393	CcSEcCtD
Bexarotene—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.1e-05	0.000393	CcSEcCtD
Bexarotene—Vertigo—Losartan—type 2 diabetes mellitus	8.09e-05	0.000392	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.09e-05	0.000392	CcSEcCtD
Bexarotene—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.09e-05	0.000392	CcSEcCtD
Bexarotene—Somnolence—Valsartan—type 2 diabetes mellitus	8.08e-05	0.000391	CcSEcCtD
Bexarotene—Syncope—Losartan—type 2 diabetes mellitus	8.08e-05	0.000391	CcSEcCtD
Bexarotene—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.07e-05	0.000391	CcSEcCtD
Bexarotene—Leukopenia—Losartan—type 2 diabetes mellitus	8.06e-05	0.000391	CcSEcCtD
Bexarotene—Discomfort—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.00039	CcSEcCtD
Bexarotene—Skin disorder—Metformin—type 2 diabetes mellitus	8.04e-05	0.000389	CcSEcCtD
Bexarotene—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8e-05	0.000388	CcSEcCtD
Bexarotene—Dyspepsia—Valsartan—type 2 diabetes mellitus	8e-05	0.000388	CcSEcCtD
Bexarotene—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.97e-05	0.000386	CcSEcCtD
Bexarotene—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000386	CcSEcCtD
Bexarotene—Palpitations—Losartan—type 2 diabetes mellitus	7.96e-05	0.000386	CcSEcCtD
Bexarotene—Nausea—Glimepiride—type 2 diabetes mellitus	7.94e-05	0.000384	CcSEcCtD
Bexarotene—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000384	CcSEcCtD
Bexarotene—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.92e-05	0.000384	CcSEcCtD
Bexarotene—Nausea—Sitagliptin—type 2 diabetes mellitus	7.91e-05	0.000383	CcSEcCtD
Bexarotene—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.91e-05	0.000383	CcSEcCtD
Bexarotene—Asthenia—Glyburide—type 2 diabetes mellitus	7.91e-05	0.000383	CcSEcCtD
Bexarotene—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.9e-05	0.000383	CcSEcCtD
Bexarotene—Anorexia—Metformin—type 2 diabetes mellitus	7.89e-05	0.000382	CcSEcCtD
Bexarotene—Cough—Losartan—type 2 diabetes mellitus	7.86e-05	0.000381	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.85e-05	0.00038	CcSEcCtD
Bexarotene—Alopecia—Ramipril—type 2 diabetes mellitus	7.84e-05	0.00038	CcSEcCtD
Bexarotene—Fatigue—Valsartan—type 2 diabetes mellitus	7.84e-05	0.00038	CcSEcCtD
Bexarotene—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.82e-05	0.000379	CcSEcCtD
Bexarotene—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.82e-05	0.000379	CcSEcCtD
Bexarotene—Oedema—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000378	CcSEcCtD
Bexarotene—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.81e-05	0.000378	CcSEcCtD
Bexarotene—Pruritus—Glyburide—type 2 diabetes mellitus	7.8e-05	0.000378	CcSEcCtD
Bexarotene—Constipation—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000377	CcSEcCtD
Bexarotene—Infection—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000376	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000376	CcSEcCtD
Bexarotene—Fatigue—Orlistat—type 2 diabetes mellitus	7.74e-05	0.000375	CcSEcCtD
Bexarotene—Erythema—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000374	CcSEcCtD
Bexarotene—Malnutrition—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000374	CcSEcCtD
Bexarotene—Shock—Irbesartan—type 2 diabetes mellitus	7.69e-05	0.000372	CcSEcCtD
Bexarotene—Pain—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000372	CcSEcCtD
Bexarotene—Arthralgia—Losartan—type 2 diabetes mellitus	7.67e-05	0.000371	CcSEcCtD
Bexarotene—Chest pain—Losartan—type 2 diabetes mellitus	7.67e-05	0.000371	CcSEcCtD
Bexarotene—Myalgia—Losartan—type 2 diabetes mellitus	7.67e-05	0.000371	CcSEcCtD
Bexarotene—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.66e-05	0.000371	CcSEcCtD
Bexarotene—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.66e-05	0.000371	CcSEcCtD
Bexarotene—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.00037	CcSEcCtD
Bexarotene—Anxiety—Losartan—type 2 diabetes mellitus	7.64e-05	0.00037	CcSEcCtD
Bexarotene—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000369	CcSEcCtD
Bexarotene—Rash—Bromocriptine—type 2 diabetes mellitus	7.6e-05	0.000368	CcSEcCtD
Bexarotene—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.59e-05	0.000368	CcSEcCtD
Bexarotene—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000368	CcSEcCtD
Bexarotene—Tension—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000367	CcSEcCtD
Bexarotene—Discomfort—Losartan—type 2 diabetes mellitus	7.58e-05	0.000367	CcSEcCtD
Bexarotene—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000366	CcSEcCtD
Bexarotene—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000366	CcSEcCtD
Bexarotene—Headache—Bromocriptine—type 2 diabetes mellitus	7.55e-05	0.000366	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.54e-05	0.000365	CcSEcCtD
Bexarotene—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.54e-05	0.000365	CcSEcCtD
Bexarotene—Nervousness—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000363	CcSEcCtD
Bexarotene—Dry mouth—Losartan—type 2 diabetes mellitus	7.5e-05	0.000363	CcSEcCtD
Bexarotene—Anorexia—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000361	CcSEcCtD
Bexarotene—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.43e-05	0.00036	CcSEcCtD
Bexarotene—Paraesthesia—Metformin—type 2 diabetes mellitus	7.43e-05	0.00036	CcSEcCtD
Bexarotene—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.43e-05	0.00036	CcSEcCtD
Bexarotene—Confusional state—Losartan—type 2 diabetes mellitus	7.41e-05	0.000359	CcSEcCtD
Bexarotene—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.4e-05	0.000359	CcSEcCtD
Bexarotene—Dyspnoea—Metformin—type 2 diabetes mellitus	7.38e-05	0.000357	CcSEcCtD
Bexarotene—Somnolence—Metformin—type 2 diabetes mellitus	7.36e-05	0.000356	CcSEcCtD
Bexarotene—Oedema—Losartan—type 2 diabetes mellitus	7.35e-05	0.000356	CcSEcCtD
Bexarotene—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.35e-05	0.000356	CcSEcCtD
Bexarotene—Infection—Losartan—type 2 diabetes mellitus	7.3e-05	0.000354	CcSEcCtD
Bexarotene—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.29e-05	0.000353	CcSEcCtD
Bexarotene—Dyspepsia—Metformin—type 2 diabetes mellitus	7.29e-05	0.000353	CcSEcCtD
Bexarotene—Shock—Losartan—type 2 diabetes mellitus	7.23e-05	0.00035	CcSEcCtD
Bexarotene—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.21e-05	0.000349	CcSEcCtD
Bexarotene—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.2e-05	0.000349	CcSEcCtD
Bexarotene—Decreased appetite—Metformin—type 2 diabetes mellitus	7.2e-05	0.000349	CcSEcCtD
Bexarotene—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.19e-05	0.000348	CcSEcCtD
Bexarotene—Tachycardia—Losartan—type 2 diabetes mellitus	7.18e-05	0.000348	CcSEcCtD
Bexarotene—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000347	CcSEcCtD
Bexarotene—Nausea—Bromocriptine—type 2 diabetes mellitus	7.16e-05	0.000347	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.15e-05	0.000346	CcSEcCtD
Bexarotene—Fatigue—Metformin—type 2 diabetes mellitus	7.14e-05	0.000346	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000345	CcSEcCtD
Bexarotene—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.11e-05	0.000344	CcSEcCtD
Bexarotene—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000344	CcSEcCtD
Bexarotene—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000344	CcSEcCtD
Bexarotene—Asthenia—Gliclazide—type 2 diabetes mellitus	7.1e-05	0.000344	CcSEcCtD
Bexarotene—Agitation—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000344	CcSEcCtD
Bexarotene—Constipation—Metformin—type 2 diabetes mellitus	7.08e-05	0.000343	CcSEcCtD
Bexarotene—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.01e-05	0.00034	CcSEcCtD
Bexarotene—Anorexia—Losartan—type 2 diabetes mellitus	7.01e-05	0.000339	CcSEcCtD
Bexarotene—Vomiting—Glyburide—type 2 diabetes mellitus	7.01e-05	0.000339	CcSEcCtD
Bexarotene—Pruritus—Gliclazide—type 2 diabetes mellitus	7e-05	0.000339	CcSEcCtD
Bexarotene—Malaise—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000337	CcSEcCtD
Bexarotene—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000337	CcSEcCtD
Bexarotene—Rash—Glyburide—type 2 diabetes mellitus	6.95e-05	0.000337	CcSEcCtD
Bexarotene—Somnolence—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000336	CcSEcCtD
Bexarotene—Dermatitis—Glyburide—type 2 diabetes mellitus	6.94e-05	0.000336	CcSEcCtD
Bexarotene—Vertigo—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000336	CcSEcCtD
Bexarotene—Syncope—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000336	CcSEcCtD
Bexarotene—Leukopenia—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000335	CcSEcCtD
Bexarotene—Headache—Glyburide—type 2 diabetes mellitus	6.9e-05	0.000334	CcSEcCtD
Bexarotene—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.000333	CcSEcCtD
Bexarotene—Palpitations—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000331	CcSEcCtD
Bexarotene—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.82e-05	0.00033	CcSEcCtD
Bexarotene—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000329	CcSEcCtD
Bexarotene—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000329	CcSEcCtD
Bexarotene—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.77e-05	0.000328	CcSEcCtD
Bexarotene—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.77e-05	0.000328	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000327	CcSEcCtD
Bexarotene—Cough—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000326	CcSEcCtD
Bexarotene—Fatigue—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000326	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.7e-05	0.000324	CcSEcCtD
Bexarotene—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.7e-05	0.000324	CcSEcCtD
Bexarotene—Pain—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000324	CcSEcCtD
Bexarotene—Constipation—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000324	CcSEcCtD
Bexarotene—Insomnia—Losartan—type 2 diabetes mellitus	6.65e-05	0.000322	CcSEcCtD
Bexarotene—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.62e-05	0.000321	CcSEcCtD
Bexarotene—Paraesthesia—Losartan—type 2 diabetes mellitus	6.6e-05	0.00032	CcSEcCtD
Bexarotene—Chest pain—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000319	CcSEcCtD
Bexarotene—Myalgia—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000319	CcSEcCtD
Bexarotene—Arthralgia—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000319	CcSEcCtD
Bexarotene—Dyspnoea—Losartan—type 2 diabetes mellitus	6.55e-05	0.000317	CcSEcCtD
Bexarotene—Anxiety—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000317	CcSEcCtD
Bexarotene—Nausea—Glyburide—type 2 diabetes mellitus	6.54e-05	0.000317	CcSEcCtD
Bexarotene—Abdominal pain—Metformin—type 2 diabetes mellitus	6.54e-05	0.000317	CcSEcCtD
Bexarotene—Dizziness—Gliclazide—type 2 diabetes mellitus	6.54e-05	0.000317	CcSEcCtD
Bexarotene—Somnolence—Losartan—type 2 diabetes mellitus	6.54e-05	0.000317	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000316	CcSEcCtD
Bexarotene—Asthenia—Valsartan—type 2 diabetes mellitus	6.52e-05	0.000316	CcSEcCtD
Bexarotene—Discomfort—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000315	CcSEcCtD
Bexarotene—Dyspepsia—Losartan—type 2 diabetes mellitus	6.47e-05	0.000313	CcSEcCtD
Bexarotene—Asthenia—Orlistat—type 2 diabetes mellitus	6.44e-05	0.000312	CcSEcCtD
Bexarotene—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000312	CcSEcCtD
Bexarotene—Pruritus—Valsartan—type 2 diabetes mellitus	6.43e-05	0.000312	CcSEcCtD
Bexarotene—Dry mouth—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000312	CcSEcCtD
Bexarotene—Decreased appetite—Losartan—type 2 diabetes mellitus	6.39e-05	0.00031	CcSEcCtD
Bexarotene—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000309	CcSEcCtD
Bexarotene—Confusional state—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000308	CcSEcCtD
Bexarotene—Pruritus—Orlistat—type 2 diabetes mellitus	6.36e-05	0.000308	CcSEcCtD
Bexarotene—Fatigue—Losartan—type 2 diabetes mellitus	6.34e-05	0.000307	CcSEcCtD
Bexarotene—Oedema—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000305	CcSEcCtD
Bexarotene—Vomiting—Gliclazide—type 2 diabetes mellitus	6.29e-05	0.000305	CcSEcCtD
Bexarotene—Pain—Losartan—type 2 diabetes mellitus	6.29e-05	0.000305	CcSEcCtD
Bexarotene—Constipation—Losartan—type 2 diabetes mellitus	6.29e-05	0.000305	CcSEcCtD
Bexarotene—Rash—Gliclazide—type 2 diabetes mellitus	6.24e-05	0.000302	CcSEcCtD
Bexarotene—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.000302	CcSEcCtD
Bexarotene—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000301	CcSEcCtD
Bexarotene—Shock—Ramipril—type 2 diabetes mellitus	6.2e-05	0.0003	CcSEcCtD
Bexarotene—Headache—Gliclazide—type 2 diabetes mellitus	6.2e-05	0.0003	CcSEcCtD
Bexarotene—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000299	CcSEcCtD
Bexarotene—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000299	CcSEcCtD
Bexarotene—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000299	CcSEcCtD
Bexarotene—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000299	CcSEcCtD
Bexarotene—Tachycardia—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000298	CcSEcCtD
Bexarotene—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000298	CcSEcCtD
Bexarotene—Skin disorder—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000297	CcSEcCtD
Bexarotene—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000295	CcSEcCtD
Bexarotene—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.06e-05	0.000293	CcSEcCtD
Bexarotene—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.01e-05	0.000291	CcSEcCtD
Bexarotene—Dizziness—Valsartan—type 2 diabetes mellitus	6.01e-05	0.000291	CcSEcCtD
Bexarotene—Anorexia—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000291	CcSEcCtD
Bexarotene—Dizziness—Orlistat—type 2 diabetes mellitus	5.94e-05	0.000288	CcSEcCtD
Bexarotene—Asthenia—Metformin—type 2 diabetes mellitus	5.94e-05	0.000288	CcSEcCtD
Bexarotene—Nausea—Gliclazide—type 2 diabetes mellitus	5.88e-05	0.000285	CcSEcCtD
Bexarotene—Pruritus—Metformin—type 2 diabetes mellitus	5.86e-05	0.000284	CcSEcCtD
Bexarotene—Abdominal pain—Losartan—type 2 diabetes mellitus	5.81e-05	0.000282	CcSEcCtD
Bexarotene—Body temperature increased—Losartan—type 2 diabetes mellitus	5.81e-05	0.000282	CcSEcCtD
Bexarotene—Vomiting—Valsartan—type 2 diabetes mellitus	5.78e-05	0.00028	CcSEcCtD
Bexarotene—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.76e-05	0.000279	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000278	CcSEcCtD
Bexarotene—Rash—Valsartan—type 2 diabetes mellitus	5.73e-05	0.000278	CcSEcCtD
Bexarotene—Dermatitis—Valsartan—type 2 diabetes mellitus	5.73e-05	0.000277	CcSEcCtD
Bexarotene—Vomiting—Orlistat—type 2 diabetes mellitus	5.71e-05	0.000277	CcSEcCtD
Bexarotene—Insomnia—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000276	CcSEcCtD
Bexarotene—Headache—Valsartan—type 2 diabetes mellitus	5.69e-05	0.000276	CcSEcCtD
Bexarotene—Diarrhoea—Metformin—type 2 diabetes mellitus	5.66e-05	0.000274	CcSEcCtD
Bexarotene—Rash—Orlistat—type 2 diabetes mellitus	5.66e-05	0.000274	CcSEcCtD
Bexarotene—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000274	CcSEcCtD
Bexarotene—Dermatitis—Orlistat—type 2 diabetes mellitus	5.66e-05	0.000274	CcSEcCtD
Bexarotene—Headache—Orlistat—type 2 diabetes mellitus	5.63e-05	0.000273	CcSEcCtD
Bexarotene—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000272	CcSEcCtD
Bexarotene—Asthenia—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000271	CcSEcCtD
Bexarotene—Somnolence—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000271	CcSEcCtD
Bexarotene—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000269	CcSEcCtD
Bexarotene—Pruritus—Irbesartan—type 2 diabetes mellitus	5.53e-05	0.000268	CcSEcCtD
Bexarotene—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000265	CcSEcCtD
Bexarotene—Dizziness—Metformin—type 2 diabetes mellitus	5.47e-05	0.000265	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000264	CcSEcCtD
Bexarotene—Fatigue—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000263	CcSEcCtD
Bexarotene—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.42e-05	0.000262	CcSEcCtD
Bexarotene—Nausea—Valsartan—type 2 diabetes mellitus	5.4e-05	0.000262	CcSEcCtD
Bexarotene—Constipation—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000261	CcSEcCtD
Bexarotene—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000259	CcSEcCtD
Bexarotene—Nausea—Orlistat—type 2 diabetes mellitus	5.34e-05	0.000258	CcSEcCtD
Bexarotene—Asthenia—Losartan—type 2 diabetes mellitus	5.27e-05	0.000256	CcSEcCtD
Bexarotene—Vomiting—Metformin—type 2 diabetes mellitus	5.26e-05	0.000255	CcSEcCtD
Bexarotene—Rash—Metformin—type 2 diabetes mellitus	5.22e-05	0.000253	CcSEcCtD
Bexarotene—Dermatitis—Metformin—type 2 diabetes mellitus	5.21e-05	0.000253	CcSEcCtD
Bexarotene—Pruritus—Losartan—type 2 diabetes mellitus	5.2e-05	0.000252	CcSEcCtD
Bexarotene—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000252	CcSEcCtD
Bexarotene—Headache—Metformin—type 2 diabetes mellitus	5.19e-05	0.000251	CcSEcCtD
Bexarotene—Dizziness—Irbesartan—type 2 diabetes mellitus	5.17e-05	0.00025	CcSEcCtD
Bexarotene—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.15e-05	0.00025	CcSEcCtD
Bexarotene—Diarrhoea—Losartan—type 2 diabetes mellitus	5.03e-05	0.000244	CcSEcCtD
Bexarotene—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000241	CcSEcCtD
Bexarotene—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000241	CcSEcCtD
Bexarotene—Vomiting—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000241	CcSEcCtD
Bexarotene—Rash—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000239	CcSEcCtD
Bexarotene—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000238	CcSEcCtD
Bexarotene—Nausea—Metformin—type 2 diabetes mellitus	4.92e-05	0.000238	CcSEcCtD
Bexarotene—Headache—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000237	CcSEcCtD
Bexarotene—Dizziness—Losartan—type 2 diabetes mellitus	4.86e-05	0.000235	CcSEcCtD
Bexarotene—Vomiting—Losartan—type 2 diabetes mellitus	4.67e-05	0.000226	CcSEcCtD
Bexarotene—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000225	CcSEcCtD
Bexarotene—Nausea—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000225	CcSEcCtD
Bexarotene—Rash—Losartan—type 2 diabetes mellitus	4.64e-05	0.000225	CcSEcCtD
Bexarotene—Dermatitis—Losartan—type 2 diabetes mellitus	4.63e-05	0.000224	CcSEcCtD
Bexarotene—Headache—Losartan—type 2 diabetes mellitus	4.61e-05	0.000223	CcSEcCtD
Bexarotene—Asthenia—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000219	CcSEcCtD
Bexarotene—Pruritus—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000216	CcSEcCtD
Bexarotene—Nausea—Losartan—type 2 diabetes mellitus	4.37e-05	0.000212	CcSEcCtD
Bexarotene—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000209	CcSEcCtD
Bexarotene—Dizziness—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000202	CcSEcCtD
Bexarotene—Vomiting—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000194	CcSEcCtD
Bexarotene—Rash—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000193	CcSEcCtD
Bexarotene—Dermatitis—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000192	CcSEcCtD
Bexarotene—Headache—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000191	CcSEcCtD
Bexarotene—Nausea—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000181	CcSEcCtD
Bexarotene—RXRA—Gene Expression—NOTCH2—type 2 diabetes mellitus	2e-05	0.000176	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC9A1—type 2 diabetes mellitus	1.99e-05	0.000176	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CETP—type 2 diabetes mellitus	1.97e-05	0.000174	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.94e-05	0.00017	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AR—type 2 diabetes mellitus	1.87e-05	0.000165	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RELA—type 2 diabetes mellitus	1.85e-05	0.000163	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	1.85e-05	0.000163	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	1.85e-05	0.000163	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.84e-05	0.000162	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SNAP25—type 2 diabetes mellitus	1.83e-05	0.000161	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PSMD6—type 2 diabetes mellitus	1.83e-05	0.000161	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SREBF1—type 2 diabetes mellitus	1.83e-05	0.000161	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.83e-05	0.000161	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.8e-05	0.000159	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CTGF—type 2 diabetes mellitus	1.8e-05	0.000158	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMGCR—type 2 diabetes mellitus	1.78e-05	0.000157	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.76e-05	0.000155	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.76e-05	0.000155	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	1.75e-05	0.000154	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	1.75e-05	0.000154	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.75e-05	0.000154	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADRA2A—type 2 diabetes mellitus	1.75e-05	0.000154	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.72e-05	0.000152	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.71e-05	0.000151	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SIRT1—type 2 diabetes mellitus	1.7e-05	0.00015	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.7e-05	0.00015	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2E1—type 2 diabetes mellitus	1.68e-05	0.000148	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	1.67e-05	0.000147	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC2A1—type 2 diabetes mellitus	1.66e-05	0.000146	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP1A2—type 2 diabetes mellitus	1.66e-05	0.000146	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.65e-05	0.000146	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP3A4—type 2 diabetes mellitus	1.62e-05	0.000142	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.61e-05	0.000142	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC2A4—type 2 diabetes mellitus	1.59e-05	0.00014	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GCG—type 2 diabetes mellitus	1.59e-05	0.00014	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—type 2 diabetes mellitus	1.58e-05	0.000139	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NFKB1—type 2 diabetes mellitus	1.56e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	1.54e-05	0.000136	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	1.54e-05	0.000136	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.54e-05	0.000135	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR3C1—type 2 diabetes mellitus	1.51e-05	0.000133	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.51e-05	0.000133	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.5e-05	0.000133	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.49e-05	0.000132	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	1.49e-05	0.000131	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.49e-05	0.000131	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	1.49e-05	0.000131	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	1.49e-05	0.000131	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	1.49e-05	0.000131	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SRC—type 2 diabetes mellitus	1.46e-05	0.000128	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	1.44e-05	0.000127	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—type 2 diabetes mellitus	1.42e-05	0.000125	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARA—type 2 diabetes mellitus	1.42e-05	0.000125	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.4e-05	0.000123	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.39e-05	0.000122	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GNB3—type 2 diabetes mellitus	1.37e-05	0.000121	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.37e-05	0.000121	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMOX1—type 2 diabetes mellitus	1.36e-05	0.00012	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	1.36e-05	0.00012	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	1.36e-05	0.00012	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAT—type 2 diabetes mellitus	1.35e-05	0.000118	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	1.33e-05	0.000117	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOB—type 2 diabetes mellitus	1.31e-05	0.000115	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—type 2 diabetes mellitus	1.3e-05	0.000115	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EGFR—type 2 diabetes mellitus	1.28e-05	0.000112	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—type 2 diabetes mellitus	1.27e-05	0.000112	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.27e-05	0.000112	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.27e-05	0.000112	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.27e-05	0.000112	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LPL—type 2 diabetes mellitus	1.25e-05	0.00011	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADCY5—type 2 diabetes mellitus	1.22e-05	0.000108	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.22e-05	0.000107	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.22e-05	0.000107	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GPX1—type 2 diabetes mellitus	1.22e-05	0.000107	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—type 2 diabetes mellitus	1.22e-05	0.000107	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.22e-05	0.000107	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.22e-05	0.000107	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CD36—type 2 diabetes mellitus	1.19e-05	0.000104	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—type 2 diabetes mellitus	1.17e-05	0.000103	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPP2CA—type 2 diabetes mellitus	1.17e-05	0.000103	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.17e-05	0.000103	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.17e-05	0.000103	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.16e-05	0.000102	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.16e-05	0.000102	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.15e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.15e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.13e-05	9.95e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.13e-05	9.95e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.13e-05	9.95e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—type 2 diabetes mellitus	1.12e-05	9.89e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.1e-05	9.71e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARA—type 2 diabetes mellitus	1.1e-05	9.7e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.09e-05	9.64e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AGT—type 2 diabetes mellitus	1.07e-05	9.39e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.06e-05	9.35e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.06e-05	9.29e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CALM1—type 2 diabetes mellitus	1.05e-05	9.24e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.05e-05	9.21e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—type 2 diabetes mellitus	1.05e-05	9.2e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-05	9.1e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.02e-05	8.98e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.02e-05	8.96e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.02e-05	8.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	9.95e-06	8.76e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.93e-06	8.75e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.83e-06	8.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	9.83e-06	8.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	9.83e-06	8.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	9.83e-06	8.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	9.83e-06	8.65e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—type 2 diabetes mellitus	9.81e-06	8.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	9.6e-06	8.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	9.6e-06	8.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	9.6e-06	8.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	9.6e-06	8.46e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	9.52e-06	8.38e-05	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—type 2 diabetes mellitus	9.45e-06	8.32e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.24e-06	8.13e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	9.21e-06	8.11e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—type 2 diabetes mellitus	9.11e-06	8.02e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—type 2 diabetes mellitus	9.05e-06	7.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.99e-06	7.92e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.99e-06	7.92e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.94e-06	7.88e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—INS—type 2 diabetes mellitus	8.93e-06	7.86e-05	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—type 2 diabetes mellitus	8.88e-06	7.82e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.76e-06	7.72e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.76e-06	7.71e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.66e-06	7.63e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	8.56e-06	7.54e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	8.36e-06	7.36e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	8.36e-06	7.36e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	8.36e-06	7.36e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—type 2 diabetes mellitus	8.19e-06	7.21e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.01e-06	7.06e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.01e-06	7.06e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	7.99e-06	7.04e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3R1—type 2 diabetes mellitus	7.83e-06	6.9e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—type 2 diabetes mellitus	7.83e-06	6.9e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	7.83e-06	6.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	7.83e-06	6.89e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.71e-06	6.79e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.71e-06	6.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	7.68e-06	6.76e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.63e-06	6.72e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	7.63e-06	6.72e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	7.63e-06	6.72e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	7.63e-06	6.72e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	7.58e-06	6.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.58e-06	6.67e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.45e-06	6.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.45e-06	6.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.45e-06	6.56e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	7.45e-06	6.56e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	7.36e-06	6.48e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—type 2 diabetes mellitus	7.16e-06	6.31e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7e-06	6.17e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.86e-06	6.04e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.84e-06	6.03e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.84e-06	6.03e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.84e-06	6.03e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	6.72e-06	5.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	6.66e-06	5.86e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.57e-06	5.78e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.56e-06	5.77e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	6.52e-06	5.74e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.33e-06	5.58e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.33e-06	5.58e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.33e-06	5.58e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.33e-06	5.58e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	6.26e-06	5.51e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	6.19e-06	5.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	6.19e-06	5.45e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.07e-06	5.35e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	6.04e-06	5.31e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.01e-06	5.29e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.93e-06	5.22e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.93e-06	5.22e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.65e-06	4.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.27e-06	4.64e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.16e-06	4.55e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.16e-06	4.55e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	5.11e-06	4.5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.11e-06	4.5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	5.09e-06	4.48e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.06e-06	4.46e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.03e-06	4.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.03e-06	4.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.03e-06	4.43e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	5.02e-06	4.42e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5e-06	4.4e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.91e-06	4.32e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.88e-06	4.29e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.86e-06	4.27e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.74e-06	4.18e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.66e-06	4.1e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—type 2 diabetes mellitus	4.63e-06	4.08e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.56e-06	4.01e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.54e-06	4e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.51e-06	3.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.51e-06	3.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.51e-06	3.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.43e-06	3.9e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.42e-06	3.9e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.39e-06	3.87e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.37e-06	3.85e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.3e-06	3.78e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.19e-06	3.69e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.13e-06	3.63e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.11e-06	3.62e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.08e-06	3.59e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.08e-06	3.59e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.98e-06	3.51e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.92e-06	3.45e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.91e-06	3.45e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.91e-06	3.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.9e-06	3.44e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.86e-06	3.4e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—type 2 diabetes mellitus	3.6e-06	3.17e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.4e-06	2.99e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.37e-06	2.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.37e-06	2.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.36e-06	2.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.33e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.31e-06	2.92e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.22e-06	2.83e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.13e-06	2.75e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.07e-06	2.7e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.06e-06	2.69e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.01e-06	2.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3e-06	2.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.92e-06	2.57e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.92e-06	2.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.92e-06	2.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.88e-06	2.54e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.76e-06	2.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.71e-06	2.39e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.67e-06	2.35e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.63e-06	2.31e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.58e-06	2.27e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.57e-06	2.27e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.54e-06	2.24e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.24e-06	1.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.2e-06	1.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.02e-06	1.77e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.93e-06	1.7e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.93e-06	1.7e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.76e-06	1.55e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	1.18e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.86e-07	7.8e-06	CbGpPWpGaD
